株探米国株
日本語 英語
エドガーで原本を確認する
false 0001308547 0001308547 2026-01-29 2026-01-29
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

January 29, 2026

 

 

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32431   90-0199783

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Class A common stock, $0.001 par value   DLB   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Section 2 - Financial Information

ITEM 2.02 Results of Operations and Financial Condition.

The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On January 29, 2026, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended December 26, 2025. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

Section 8 – Other Events

ITEM 8.01 Other Events

Declaration of Dividend

On January 29, 2026, the Company announced a cash dividend of $0.36 per share of Class A and Class B Common Stock, payable on February 18, 2026 to stockholders of record as of the close of business on February 10, 2026.

Disclosure Channels to Disseminate Information

The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

Section 9 - Financial Statements and Exhibits

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.

  

Description

99.1    Press Release of Dolby Laboratories, Inc. dated January 29, 2026
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DOLBY LABORATORIES, INC.
By:  

/s/ Robert Park

 

Robert Park

Senior Vice President and Chief Financial Officer (Principal Financial Officer)

Date: January 29, 2026

EX-99.1 2 d36036dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Dolby Laboratories Reports First Quarter 2026 Financial Results

SAN FRANCISCO, January 29, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the first quarter of fiscal 2026.

“With a good start to the fiscal year, we are optimistic about our position in the market and confident in our growth opportunities,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “We continue to have strong momentum with Dolby Atmos and Dolby Vision, while also expanding our addressable market with our imaging patent program for content streamers and Dolby OptiView.”

First Quarter Fiscal 2026 Financial Highlights

 

   

Total revenue was $347 million, compared to $357 million for the first quarter of fiscal 2025.

 

   

GAAP net income was $53 million or $0.55 per diluted share, compared to GAAP net income of $68 million or $0.70 per diluted share for the first quarter of fiscal 2025. On a non-GAAP basis, first quarter net income was $103 million or $1.06 per diluted share, compared to $111 million or $1.14 per diluted share for the first quarter of fiscal 2025.

 

   

Dolby repurchased approximately one million shares of its common stock for approximately $70 million, and ended the quarter with approximately $207 million of stock repurchase authorization available going forward.

A complete listing of Dolby’s non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

 

   

Over 35 auto OEMs now embrace Dolby Atmos – from luxury vehicles to entry level models with baseline audio systems.

 

   

Mercedes-Benz is one of the first automakers to enable Spatial Audio with Dolby Atmos in Apple CarPlay, which will be supported across its latest line up, including the all-new electric GLC, CLA, and GLB.

 

   

Mahindra announced the first vehicle in India to support Dolby Atmos and Dolby Vision.

 

   

Qualcomm is integrating Dolby’s latest technology into its Gen 5 Snapdragon Automotive platform.

 

   

Peacock is the first streamer to embrace Dolby’s full suite of advanced picture and sound innovations, including Dolby Vision 2. Peacock also announced that it is extending the availability of Dolby Vision and Dolby Atmos across live sports over the coming year, including Sunday Night Football, the NBA, and MLB.

 

   

Hisense, TCL, and TP Vision announced various upcoming TV models that will support Dolby Vision 2.

 

   

LG unveiled its LG Sound Suite, a modular home audio system powered by Dolby Atmos FlexConnect, including the world’s first soundbar to feature the technology.

 

   

Meta began supporting Dolby Vision on Facebook after recently announcing support for Dolby Vision on Instagram.

Dividend

Today, Dolby announced a cash dividend of $0.36 per share of Class A and Class B common stock, payable on February 18, 2026, to stockholders of record as of the close of business on February 10, 2026.

Financial Outlook

Dolby’s financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing herein due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including developments concerning trade restrictions and changes in trade or diplomatic relationships, supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates.


The uncertainty resulting from these factors has greatly reduced visibility into Dolby’s future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see “Forward-Looking Statements” in this press release for a description of certain risks that Dolby faces, and the section captioned “Risk Factors” in its Quarterly Report on Form 10-Q for the first quarter of fiscal 2026, to be filed on or around the date hereof.

Dolby is providing the following estimates for its second quarter of fiscal 2026:

 

   

Total revenue is estimated to range from $375 million to $405 million.

 

   

Licensing revenue is estimated to range from $350 million to $380 million.

 

   

Gross margins are anticipated to be approximately 90% on a GAAP basis and approximately 91% on a non-GAAP basis.

 

   

Operating expenses are anticipated to range from $230 million to $240 million on a GAAP basis and from $195 million to $205 million on a non-GAAP basis.

 

   

Effective tax rate is anticipated to be around 23% on a GAAP basis and around 21% on a non-GAAP basis.

 

   

Diluted earnings per share is anticipated to range from $0.94 to $1.09 on a GAAP basis and from $1.29 to $1.44 on a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2026:

 

   

Total revenue is expected to range from $1.4 billion to $1.45 billion.

 

   

Licensing revenue is estimated to range from $1.295 billion to $1.345 billion.

 

   

Gross margins are anticipated to be approximately 88% on a GAAP basis and approximately 90% on a non-GAAP basis.

 

   

Operating expenses are anticipated to range from $930 million to $950 million on a GAAP basis and from $780 million to $800 million on a non-GAAP basis.

 

   

Dolby expects operating margins to be approximately 21% on a GAAP basis and to be approximately 34% on a non-GAAP basis.

 

   

Effective tax rate is anticipated to be around 23% on a GAAP basis and around 21% on a non-GAAP basis.

 

   

Diluted earnings per share is anticipated to range from $2.71 to $2.86 on a GAAP basis and from $4.30 to $4.45 on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss first quarter fiscal 2026 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, January 29, 2026. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.

A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Thursday, January 29, 2026, until 8:59 p.m. PT (11:59 p.m. ET) on Thursday, February 5, 2026 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.


Non-GAAP Financial Information

To supplement Dolby’s financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby’s operating results in a manner that focuses on what Dolby’s management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby’s management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby’s management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby’s business, including as a means to evaluate period-to-period comparisons. Dolby’s management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby’s GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.


Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the second quarter of fiscal 2026 and full year fiscal 2026, Dolby’s ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are “forward-looking statements” that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management’s current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage; the timing of Dolby’s receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby’s ability to develop, maintain, and strengthen relationships with industry participants; Dolby’s ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture and cinema industries generally; Dolby’s ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby’s SEC filings and reports, including the risks identified under the section captioned “Risk Factors” in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby

Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide across all their favorite devices. We partner with artists, storytellers, and the brands you love to transform entertainment and digital experiences through groundbreaking innovations like Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby OptiView.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby OptiView, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.


DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts; unaudited)

 

     Fiscal Quarter Ended  
     December 26,
2025
    December 27,
2024
 

Revenue:

    

Licensing

   $ 319,771     $ 330,479  

Products and services

     26,935       26,520  
  

 

 

   

 

 

 

Total revenue

     346,706       356,999  
  

 

 

   

 

 

 

Cost of revenue:

    

Cost of licensing

     20,762       21,110  

Cost of products and services

     22,446       19,664  
  

 

 

   

 

 

 

Total cost of revenue

     43,208       40,774  
  

 

 

   

 

 

 

Gross profit

     303,498       316,225  
  

 

 

   

 

 

 

Operating expenses:

    

Research and development

     69,077       66,638  

Sales and marketing

     91,552       94,399  

General and administrative

     70,243       70,092  

Restructuring charges

     10,466       5,216  
  

 

 

   

 

 

 

Total operating expenses

     241,338       236,345  
  

 

 

   

 

 

 

Operating income

     62,160       79,880  
  

 

 

   

 

 

 

Other income/(expense):

    

Interest income/(expense), net

     4,118       2,646  

Other income, net

     5,324       3,525  
  

 

 

   

 

 

 

Total other income

     9,442       6,171  
  

 

 

   

 

 

 

Income before income taxes

     71,602       86,051  

Provision for income taxes

     (17,921     (17,981
  

 

 

   

 

 

 

Net income including noncontrolling interest

     53,681       68,070  

Less: net income attributable to noncontrolling interest

     (354     (248
  

 

 

   

 

 

 

Net income attributable to Dolby Laboratories, Inc.

   $ 53,327     $ 67,822  
  

 

 

   

 

 

 

Net income per share:

    

Basic

   $ 0.56     $ 0.71  

Diluted

   $ 0.55     $ 0.70  

Weighted-average shares outstanding:

    

Basic

     95,466       95,615  

Diluted

     96,518       97,147  


DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands; unaudited)

 

     December 26,
2025
    September 26,
2025
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 643,845     $ 701,893  

Restricted cash

     83,721       91,468  

Short-term investments

     739       703  

Accounts receivable, net

     373,091       331,096  

Contract assets, net

     198,266       180,804  

Inventories, net

     31,264       30,424  

Prepaid expenses and other current assets

     77,136       51,873  
  

 

 

   

 

 

 

Total current assets

     1,408,062       1,388,261  

Long-term investments

     85,022       80,205  

Property, plant, and equipment, net

     466,720       470,608  

Operating lease right-of-use assets

     35,569       33,204  

Goodwill and intangible assets, net

     894,320       926,957  

Deferred taxes

     214,346       214,361  

Other non-current assets

     88,084       114,164  
  

 

 

   

 

 

 

Total assets

   $ 3,192,123     $ 3,227,760  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    
Current liabilities:     

Accounts payable

   $ 8,668     $ 17,840  

Accrued liabilities

     376,212       369,256  

Income taxes payable

     11,208       8,928  

Contract liabilities

     37,094       31,382  

Operating lease liabilities

     10,325       10,384  
  

 

 

   

 

 

 

Total current liabilities

     443,507       437,790  

Non-current contract liabilities

     25,159       29,687  

Non-current operating lease liabilities

     30,314       28,494  

Other non-current liabilities

     90,272       99,843  
  

 

 

   

 

 

 

Total liabilities

     589,252       595,814  

Stockholders’ equity:

    

Class A common stock

     54       54  

Class B common stock

     40       40  

Retained earnings

     2,604,358       2,634,980  

Accumulated other comprehensive loss

     (10,777     (12,517
  

 

 

   

 

 

 

Total stockholders’ equity – Dolby Laboratories, Inc.

     2,593,675       2,622,557  

Noncontrolling interest

     9,196       9,389  
  

 

 

   

 

 

 

Total stockholders’ equity

     2,602,871       2,631,946  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 3,192,123     $ 3,227,760  
  

 

 

   

 

 

 


DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands; unaudited)

 

     Fiscal Quarter Ended  
     December 26,
2025
    December 27,
2024
 

Operating activities:

    

Net income including noncontrolling interest

   $ 53,681     $ 68,070  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     24,145       22,362  

Stock-based compensation

     37,211       36,070  

Amortization of operating lease right-of-use assets

     2,668       2,835  

Provision for credit losses

     792       730  

Deferred income taxes

     16       (7,307

Share of net income of equity method investees, net of cash distributions

     (5,276     (911

Other non-cash items affecting net income

     (1,890     1,191  

Changes in operating assets and liabilities:

    

Accounts receivable, net

     (82,956     (24,647

Contract assets, net

     (19,824     (23,416

Inventories

     879       1,340  

Operating lease right-of-use assets

     (4,810     (2,487

Prepaid expenses and other assets

     (3,152     13,528  

Accounts payable and accrued liabilities

     43,575       4,804  

Income taxes, net

     4,394       15,305  

Contract liabilities

     6,828       3,691  

Operating lease liabilities

     1,552       (798

Other non-current liabilities

     (3,034     (3,581
  

 

 

   

 

 

 

Net cash provided by operating activities

     54,799       106,779  
  

 

 

   

 

 

 

Investing activities:

    

Proceeds from sale of intangible assets

     6,623       —   

Purchases of property, plant, and equipment

     (4,628     (6,779

Business combinations, net of cash and restricted cash acquired, and other related payments

     —        (1,362

Purchases of intangible assets

     (750     —   
  

 

 

   

 

 

 

Net cash provided by/(used in) investing activities

     1,245       (8,141
  

 

 

   

 

 

 

Financing activities:

    

Proceeds from issuance of common stock

     14,253       22,157  

Repurchase of common stock

     (70,005     (15,000

Payment of cash dividend

     (34,339     (31,548

Distributions to noncontrolling interest

     (547     (740

Shares repurchased for tax withholdings on vesting of restricted stock

     (31,196     (32,440
  

 

 

   

 

 

 

Net cash used in financing activities

     (121,834     (57,571
  

 

 

   

 

 

 

Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash

     (5     (7,162
  

 

 

   

 

 

 

Net increase/(decrease) in cash, cash equivalents, and restricted cash

     (65,795     33,905  

Cash, cash equivalents, and restricted cash at beginning of period

     793,361       577,752  
  

 

 

   

 

 

 

Cash, cash equivalents, and restricted cash at end of period

   $ 727,566     $ 611,657  
  

 

 

   

 

 

 


Licensing Revenue by Market

(unaudited)

The following table presents the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands, except percentage amounts):

 

     Fiscal Quarter Ended  
Market    December 26,
2025
    December 27,
2024
 

Broadcast

   $ 100,263        31   $ 115,762        35

Mobile

     74,949        23     61,524        19

CE

     45,602        14     49,457        15

PC

     28,717        9     31,256        9

Other

     70,240        23     72,480        22
  

 

 

    

 

 

   

 

 

    

 

 

 

Total licensing revenue

   $ 319,771        100   $ 330,479        100
  

 

 

    

 

 

   

 

 

    

 

 

 

GAAP to Non-GAAP Reconciliations

(unaudited)

The following tables present Dolby’s GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the first quarters of fiscal 2026 and fiscal 2025:

 

Net income:    Fiscal Quarter Ended  
(in thousands)    December 26,
2025
    December 27,
2024
 

GAAP net income attributable to Dolby Laboratories, Inc.

   $ 53,327     $ 67,822  

Stock-based compensation (1)

     37,211       36,070  

Amortization of acquisition-related intangibles (2)

     9,867       10,647  

Restructuring charges

     10,466       5,216  

Income tax adjustments

     (8,370     (8,886
  

 

 

   

 

 

 

Non-GAAP net income attributable to Dolby Laboratories, Inc.

   $ 102,501     $ 110,869  
  

 

 

   

 

 

 

(1)   Stock-based compensation included in above line items:

    

Cost of products and services

   $ 530     $ 487  

Research and development

     11,568       10,984  

Sales and marketing

     12,705       12,645  

General and administrative

     12,408       11,954  

(2)   Amortization of acquisition-related intangibles included in above line items:

    

Cost of licensing

   $ 6,590     $ 6,704  

Cost of products and services

     768       834  

Sales and marketing

     353       754  

General and administrative

     1,715       1,872  

Other income, net

     441       483  
Diluted earnings per share:    Fiscal Quarter Ended  
     December 26,
2025
    December 27,
2024
 

GAAP diluted earnings per share

   $ 0.55     $ 0.70  

Stock-based compensation

     0.39       0.37  

Amortization of acquisition-related intangibles

     0.10       0.11  

Restructuring charges

     0.11       0.05  

Income tax adjustments

     (0.09     (0.09
  

 

 

   

 

 

 

Non-GAAP diluted earnings per share

   $ 1.06     $ 1.14  

Weighted-average shares outstanding - diluted (in thousands)

     96,518       97,147  
  

 

 

   

 

 

 


The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the second quarter of fiscal 2026 and full year fiscal 2026 included in this release:

 

Gross margin:    Q2 2026     Fiscal 2026  

GAAP gross margin

     90.0     88.0

Stock-based compensation

     0.1     0.1

Amortization of acquisition-related intangibles

     0.9     1.9
  

 

 

   

 

 

 

Non-GAAP gross margin

     91.0     90.0
  

 

 

   

 

 

 
Operating expenses (in millions):    Q2 2026     Fiscal 2026  

GAAP operating expenses (low - high end of range)

   $ 230 -$240     $ 930 -$950  

Stock-based compensation

     (31     (128

Amortization of acquisition-related intangibles

     (2     (10

Restructuring charges

     (2     (12
  

 

 

   

 

 

 

Non-GAAP operating expenses (low - high end of range)

   $ 195 -$205     $ 780 -$800  
  

 

 

   

 

 

 
Operating margin:          Fiscal 2026  

GAAP operating margin

       21 % +/- 

Stock-based compensation

       9

Amortization of acquisition-related intangibles

       3

Restructuring charges

       1
    

 

 

 

Non-GAAP operating margin

       34 % +/- 
    

 

 

 
Effective tax rate:    Q2 2026     Fiscal 2026  

GAAP effective tax rate

     23.0     23.0

Stock-based compensation (low - high end of range)

     (2%) - 1     (2%) - 0

Amortization of acquisition-related intangibles (low - high end of range)

     (1%) - 0     (1%) - 0
  

 

 

   

 

 

 

Non-GAAP effective tax rate

     21.0     21.0
  

 

 

   

 

 

 

 

Diluted earnings per share:    Q2 2026     Fiscal 2026  
     Low     High     Low     High  

GAAP diluted earnings per share (low - high end of range)

   $ 0.94     $ 1.09     $ 2.71     $ 2.86  

Stock-based compensation

     0.32       0.32       1.34       1.34  

Amortization of acquisition-related intangibles

     0.11       0.11       0.43       0.43  

Restructuring charges

     0.02       0.02       0.13       0.13  

Income tax adjustments

     (0.10     (0.10     (0.31     (0.31

Non-GAAP diluted earnings per share (low - high end of range)

   $ 1.29     $ 1.44     $ 4.30     $ 4.45  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average shares outstanding - diluted (in thousands)

     95,900       95,900       95,700       95,700  
  

 

 

   

 

 

   

 

 

   

 

 

 

Investor Contact:

Peter Goldmacher

415-254-7415

peter.goldmacher@dolby.com

Media Contact:

media@dolby.com